GxP News

0 КОММЕНТАРИИ
370 ПОСТЫ

Публикации автора

Ministry of Health approved standards anti-COVID-19 vaccination for adults

The Ministry of Health of Russia has established and sent to the regional authorities a standard operating procedure that defines the rules for organizing the...

The Ministry of Industry and Trade called the production volumes of the Sputnik V vaccine

Russia has already produced almost 6.5 million doses of two Sputnik V vaccine components for today, said the Minister of Industry and Trade Denis Manturov...

Trials of combined anti-COVID-19 vaccine Sputnik V will start in February

Trials of human combined anti-COVID-19 vaccine Sputnik V tests and AstraZeneca should start in early February, Reuters reports with reference to Alexei Repik, the head...

Russia applied for registration of the Sputnik V vaccine in the EU

The Russian Direct Investment Fund (RDIF) applied for registration of the Sputnik V vaccine in the European Union. The examination process is expected to start...

RDIF and Gamalei created an international council for the Sputnik V vaccine

The Russian Direct Investment Fund (RDIF) and the Gamalei National Research Center of Epidemiology and Microbiology announced the creation of the Sputnik V International Scientific...

Russia has developed a test system to determine the “British” strain of coronavirus

Detecting test system of coronavirus mutation found in the UK is at the final stage of testing, Rospotrebnadzor reports. "The isothermal amplification technology allows to analyze...

R-Pharm will launch production of Sputnik V vaccine by the end of January

R-Pharm, Russian pharmaceutical company will launch the production of COVID-19 vaccine Sputnik V by the end of January, RIA Novosti reports with reference to the...

Binofarm Group will produce Indian manufacturer favipiravir

The Binopharm Group holding, combining the Sistema AFC pharmaceutical assets, and the Indian pharmaceutical manufacturer Glenmark Pharmaceuticals agreed to localize the producing of favipiravir used...

Manufacture drugs authorization are valid only in electronic form since January

The issuance of authorizations for the drugs production, medical devices and medical activities since January 1, 2021 is possible only in the electronic version, Roszdravnadzor...

R-Pharm has registered a comprehensive solution in the field of genetic diagnostics

On January 15, R-Pharm Group announced the registration of a set of reagents MiSeq Dx v3 for nucleic acid sequencing in Russia. Due to it...